Double Medical Technology

Double Medical Technology Financial Leverage

The Financial Leverage (Equity Multiplier) of Double Medical Technology (002901.SZ) as of Oct 22, 2026 is 1.38. In the previous year, Financial Leverage (Equity Multiplier) was 1.44 — a change of -3.89% (lower).

Financial Leverage

1.38

YoY

-3.89%

Last updated:

Financial Leverage (Equity Multiplier) of Double Medical Technology is 2025 1.38 . Financial Leverage (Equity Multiplier) of Double Medical Technology was 2024 1.44 . It decreases by -3.89% lower compared to the previous year.

The Double Medical Technology Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.16 CNY
Jan 1, 2019
1.30 CNY
Jan 1, 2020
1.26 CNY
Jan 1, 2021
1.35 CNY
Jan 1, 2022
1.31 CNY
Jan 1, 2023
1.52 CNY
Jan 1, 2024
1.44 CNY
Jan 1, 2025
1.38 CNY
The Double Medical Technology Financial Leverage history
YEARFinancial LeverageYoY
1.38-3.89%
1.44-5.39%
1.52+15.57%
1.31-2.42%
1.35+6.98%
1.26-3.29%
1.30+12.44%
1.16+2.22%
1.13-9.71%
1.25-1.99%
1.28-36.41%
2.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Double Medical Technology Stock analysis

What does Double Medical Technology do? Double Medical Technology Inc, listed on the Shenzhen Stock Exchange under ticker 002901.SZ, operates in the Health Care sector with a focus on medical consumables. Headquartered in Xiamen, China, the company employs 3,793 full-time staff. It completed its initial public offering (IPO) on September 22, 2017. Double Medical Technology engages in the production, research and development, and sale of medical consumables, including orthopedic trauma implant materials, spinal implant materials, and nerve surgical implant materials. The company also manufactures surgical instruments. Its products are distributed both domestically within China and internationally. The firm's website is http://www.double-medical.com/. As a publicly traded entity, it provides medical products essential for surgical procedures and patient care, operating within the healthcare industry framework. The company's operations are centered around the development and supply of specialized medical devices and consumables, targeting healthcare providers and institutions globally. Double Medical Technology maintains a presence in both domestic and international markets, reflecting its strategic approach to market expansion and product distribution. Double Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Double Medical Technology stock

Financial Leverage (Equity Multiplier) of Double Medical Technology is 1.38 in 2025.

Financial Leverage (Equity Multiplier) of Double Medical Technology changed from 1.44 to 1.38, representing a -3.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Double Medical Technology since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Double Medical Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Double Medical Technology

All Key Metrics — Double Medical Technology